3/28
01:35 pm
lctx
These 2 ‘Strong Buy' Penny Stocks Could Go Boom, Say Analysts [Yahoo! Finance]
Low
Report
These 2 ‘Strong Buy' Penny Stocks Could Go Boom, Say Analysts [Yahoo! Finance]
3/18
08:17 am
lctx
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium [Yahoo! Finance]
High
Report
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium [Yahoo! Finance]
3/18
08:00 am
lctx
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium
Medium
Report
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium
3/13
08:00 am
lctx
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
Medium
Report
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
3/11
08:16 am
lctx
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting [Yahoo! Finance]
Medium
Report
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting [Yahoo! Finance]
3/11
08:00 am
lctx
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting
Medium
Report
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting
3/8
04:25 pm
lctx
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/7
10:47 pm
lctx
Lineage Cell Therapeutics Inc. Reports Q4 and Full Year 2023 Financial Results [Yahoo! Finance]
High
Report
Lineage Cell Therapeutics Inc. Reports Q4 and Full Year 2023 Financial Results [Yahoo! Finance]
3/7
04:23 pm
lctx
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/7
04:01 pm
lctx
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
High
Report
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2/29
08:21 am
lctx
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024 [Yahoo! Finance]
Low
Report
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024 [Yahoo! Finance]
2/29
08:00 am
lctx
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024
Low
Report
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024
2/13
08:00 am
lctx
Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury
Medium
Report
Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury
2/9
09:26 am
lctx
Lineage Cell Therapeutics Announces Closing of $14.0 Million Registered Direct Offering [Yahoo! Finance]
Medium
Report
Lineage Cell Therapeutics Announces Closing of $14.0 Million Registered Direct Offering [Yahoo! Finance]
2/9
09:15 am
lctx
Lineage Cell Therapeutics Announces Closing of $14.0 Million Registered Direct Offering
Medium
Report
Lineage Cell Therapeutics Announces Closing of $14.0 Million Registered Direct Offering
2/6
09:26 am
lctx
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering [Yahoo! Finance]
Low
Report
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering [Yahoo! Finance]
2/6
09:15 am
lctx
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
High
Report
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
1/17
11:37 am
lctx
Cell Line Development Market Size to Surpass USD 4.5 Billion by 2035 | Roots Analysis [Yahoo! Finance]
Low
Report
Cell Line Development Market Size to Surpass USD 4.5 Billion by 2035 | Roots Analysis [Yahoo! Finance]
1/16
08:09 am
lctx
RG6501 (OpRegen®) Phase 1/2a Results Will Be Featured at 2024 Angiogenesis Exudation and Degeneration Meeting in Presentation by Allen Ho, MD, FACS, FASRS [Yahoo! Finance]
Medium
Report
RG6501 (OpRegen®) Phase 1/2a Results Will Be Featured at 2024 Angiogenesis Exudation and Degeneration Meeting in Presentation by Allen Ho, MD, FACS, FASRS [Yahoo! Finance]
1/16
08:00 am
lctx
RG6501 (OpRegen®) Phase 1/2a Results Will Be Featured at 2024 Angiogenesis Exudation and Degeneration Meeting in Presentation by Allen Ho, MD, FACS, FASRS
Medium
Report
RG6501 (OpRegen®) Phase 1/2a Results Will Be Featured at 2024 Angiogenesis Exudation and Degeneration Meeting in Presentation by Allen Ho, MD, FACS, FASRS
1/15
03:17 am
lctx
Lineage Cell Therapeutics: Not Yet Attractive Stem Cell Company [Seeking Alpha]
Low
Report
Lineage Cell Therapeutics: Not Yet Attractive Stem Cell Company [Seeking Alpha]